Cargando…
Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021
OBJECTIVE: We sought to compare the incidence of early-onset sepsis (EOS) in infants ≥34 weeks’ gestation identified >24 hours after birth, in hospitals using the Kaiser Permanente Sepsis Risk Calculator (SRC) with hospitals using the National Institute for Health and Care Excellence (NICE) guida...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387649/ https://www.ncbi.nlm.nih.gov/pubmed/37500270 http://dx.doi.org/10.1136/bmjopen-2023-072708 |
_version_ | 1785081930220306432 |
---|---|
author | Piyasena, Chinthika Galu, Sorana Yoshida, Rie Thakkar, Devangi O'Sullivan, Joanna Longley, Catherine Evans, Katie Sweeney, Suzanne Kendall, Giles Ben-Sasi, Khadija Richards, Justin Harris, Chris Jagodzinski, Jenni Demirjian, Alicia Lamagni, Theresa Le Doare, Kirsty Heath, Paul T Battersby, Cheryl |
author_facet | Piyasena, Chinthika Galu, Sorana Yoshida, Rie Thakkar, Devangi O'Sullivan, Joanna Longley, Catherine Evans, Katie Sweeney, Suzanne Kendall, Giles Ben-Sasi, Khadija Richards, Justin Harris, Chris Jagodzinski, Jenni Demirjian, Alicia Lamagni, Theresa Le Doare, Kirsty Heath, Paul T Battersby, Cheryl |
author_sort | Piyasena, Chinthika |
collection | PubMed |
description | OBJECTIVE: We sought to compare the incidence of early-onset sepsis (EOS) in infants ≥34 weeks’ gestation identified >24 hours after birth, in hospitals using the Kaiser Permanente Sepsis Risk Calculator (SRC) with hospitals using the National Institute for Health and Care Excellence (NICE) guidance. DESIGN AND SETTING: Prospective observational population-wide cohort study involving all 26 hospitals with neonatal units colocated with maternity services across London (10 using SRC, 16 using NICE). PARTICIPANTS: All live births ≥34 weeks’ gestation between September 2020 and August 2021. OUTCOME MEASURES: EOS was defined as isolation of a bacterial pathogen in the blood or cerebrospinal fluid (CSF) culture from birth to 7 days of age. We evaluated the incidence of EOS identified by culture obtained >24 hours to 7 days after birth. We also evaluated the rate empiric antibiotics were commenced >24 hours to 7 days after birth, for a duration of ≥5 days, with negative blood or CSF cultures. RESULTS: Of 99 683 live births, 42 952 (43%) were born in SRC hospitals and 56 731 (57%) in NICE hospitals. The overall incidence of EOS (<72 hours) was 0.64/1000 live births. The incidence of EOS identified >24 hours was 2.3/100 000 (n=1) for SRC vs 7.1/100 000 (n=4) for NICE (OR 0.5, 95% CI (0.1 to 2.7)). This corresponded to (1/20) 5% (SRC) vs (4/45) 8.9% (NICE) of EOS cases (χ=0.3, p=0.59). Empiric antibiotics were commenced >24 hours to 7 days after birth in 4.4/1000 (n=187) for SRC vs 2.9/1000 (n=158) for NICE (OR 1.5, 95% CI (1.2 to 1.9)). 3111 (7%) infants received antibiotics in the first 24 hours in SRC hospitals vs 8428 (15%) in NICE hospitals. CONCLUSION: There was no significant difference in the incidence of EOS identified >24 hours after birth between SRC and NICE hospitals. SRC use was associated with 50% fewer infants receiving antibiotics in the first 24 hours of life. |
format | Online Article Text |
id | pubmed-10387649 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-103876492023-08-01 Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021 Piyasena, Chinthika Galu, Sorana Yoshida, Rie Thakkar, Devangi O'Sullivan, Joanna Longley, Catherine Evans, Katie Sweeney, Suzanne Kendall, Giles Ben-Sasi, Khadija Richards, Justin Harris, Chris Jagodzinski, Jenni Demirjian, Alicia Lamagni, Theresa Le Doare, Kirsty Heath, Paul T Battersby, Cheryl BMJ Open Paediatrics OBJECTIVE: We sought to compare the incidence of early-onset sepsis (EOS) in infants ≥34 weeks’ gestation identified >24 hours after birth, in hospitals using the Kaiser Permanente Sepsis Risk Calculator (SRC) with hospitals using the National Institute for Health and Care Excellence (NICE) guidance. DESIGN AND SETTING: Prospective observational population-wide cohort study involving all 26 hospitals with neonatal units colocated with maternity services across London (10 using SRC, 16 using NICE). PARTICIPANTS: All live births ≥34 weeks’ gestation between September 2020 and August 2021. OUTCOME MEASURES: EOS was defined as isolation of a bacterial pathogen in the blood or cerebrospinal fluid (CSF) culture from birth to 7 days of age. We evaluated the incidence of EOS identified by culture obtained >24 hours to 7 days after birth. We also evaluated the rate empiric antibiotics were commenced >24 hours to 7 days after birth, for a duration of ≥5 days, with negative blood or CSF cultures. RESULTS: Of 99 683 live births, 42 952 (43%) were born in SRC hospitals and 56 731 (57%) in NICE hospitals. The overall incidence of EOS (<72 hours) was 0.64/1000 live births. The incidence of EOS identified >24 hours was 2.3/100 000 (n=1) for SRC vs 7.1/100 000 (n=4) for NICE (OR 0.5, 95% CI (0.1 to 2.7)). This corresponded to (1/20) 5% (SRC) vs (4/45) 8.9% (NICE) of EOS cases (χ=0.3, p=0.59). Empiric antibiotics were commenced >24 hours to 7 days after birth in 4.4/1000 (n=187) for SRC vs 2.9/1000 (n=158) for NICE (OR 1.5, 95% CI (1.2 to 1.9)). 3111 (7%) infants received antibiotics in the first 24 hours in SRC hospitals vs 8428 (15%) in NICE hospitals. CONCLUSION: There was no significant difference in the incidence of EOS identified >24 hours after birth between SRC and NICE hospitals. SRC use was associated with 50% fewer infants receiving antibiotics in the first 24 hours of life. BMJ Publishing Group 2023-07-27 /pmc/articles/PMC10387649/ /pubmed/37500270 http://dx.doi.org/10.1136/bmjopen-2023-072708 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Paediatrics Piyasena, Chinthika Galu, Sorana Yoshida, Rie Thakkar, Devangi O'Sullivan, Joanna Longley, Catherine Evans, Katie Sweeney, Suzanne Kendall, Giles Ben-Sasi, Khadija Richards, Justin Harris, Chris Jagodzinski, Jenni Demirjian, Alicia Lamagni, Theresa Le Doare, Kirsty Heath, Paul T Battersby, Cheryl Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021 |
title | Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021 |
title_full | Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021 |
title_fullStr | Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021 |
title_full_unstemmed | Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021 |
title_short | Comparison of diagnoses of early-onset sepsis associated with use of Sepsis Risk Calculator versus NICE CG149: a prospective, population-wide cohort study in London, UK, 2020–2021 |
title_sort | comparison of diagnoses of early-onset sepsis associated with use of sepsis risk calculator versus nice cg149: a prospective, population-wide cohort study in london, uk, 2020–2021 |
topic | Paediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387649/ https://www.ncbi.nlm.nih.gov/pubmed/37500270 http://dx.doi.org/10.1136/bmjopen-2023-072708 |
work_keys_str_mv | AT piyasenachinthika comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT galusorana comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT yoshidarie comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT thakkardevangi comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT osullivanjoanna comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT longleycatherine comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT evanskatie comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT sweeneysuzanne comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT kendallgiles comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT bensasikhadija comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT richardsjustin comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT harrischris comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT jagodzinskijenni comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT demirjianalicia comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT lamagnitheresa comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT ledoarekirsty comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT heathpault comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT battersbycheryl comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 AT comparisonofdiagnosesofearlyonsetsepsisassociatedwithuseofsepsisriskcalculatorversusnicecg149aprospectivepopulationwidecohortstudyinlondonuk20202021 |